Biodegradable bone implant firm Inion seeks UK listing
This article was originally published in Clinica
Executive Summary
A Finnish firm developing biodegradable fixation implants is planning to raise £30m ($56m) through a listing on the UK stock market. Tampere-based Inion, whose implants are being sold around the world through distribution deals with companies including Stryker and B Braun's Aesculap division, expects to have a market capitalisation of around £80-90m after completing a placing of shares with European and other institutional investors in early December.